Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Intermittent Ceftazidime in VAP
NCT02837835Phase 3Completed
- Sponsor
- CHU de Reims
- Start
- Mar 2005
- Primary completion
- Feb 2008
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of ceftazidime in ventilator-associated pneumonia (VAP), sponsored by CHU de Reims. Started Mar 2005; status: completed.
02
Drugs
ceftazidime
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT02837835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02837835.